← All organizations
Highest phase reached
Phase 1
First clinical trial
Jan 15, 2016Last known activity
Feb 6, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 4 trials)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT05773794Reponsible party - principal investigatorN/AFeb 6, 2023
- NCT05773794Sponsor investigatorN/AFeb 6, 2023
- NCT05773794Lead sponsorN/AFeb 6, 2023
- NCT04415333CollaboratorPhase 1Sep 30, 2020
- NCT03911050Reponsible party - principal investigatorN/ANov 26, 2018
- NCT03911050Lead sponsorN/ANov 26, 2018
- NCT03911050Overall official - principal investigatorN/ANov 26, 2018
- NCT04335435Lead sponsorN/AJan 15, 2016
- NCT04335435Reponsible party - principal investigatorN/AJan 15, 2016
Details
- Last known activity
- Feb 6, 2023